We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLA
2826
DELISTED
Delta Apparel Inc.
DLA
$486K ﹤0.01%
15,602
+873
+6% +$23.4K
BCBP icon
2827
BCB Bancorp
BCBP
$157M
$484K ﹤0.01%
35,059
+1,947
+6% +$25.9K
SLCT
2828
DELISTED
Select Bancorp, Inc.
SLCT
$481K ﹤0.01%
39,034
DESP
2829
DELISTED
Despegar.com
DESP
$477K ﹤0.01%
35,339
-15,216
-30% -$180K
XERS icon
2830
Xeris Biopharma Holdings
XERS
$1.5B
$477K ﹤0.01%
67,583
ESXB
2831
DELISTED
Community Bankers Trust Corporation
ESXB
$476K ﹤0.01%
53,562
CNCE
2832
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$474K ﹤0.01%
51,302
+2,475
+5% +$17.5K
BOCH
2833
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$474K ﹤0.01%
40,924
BW icon
2834
Babcock & Wilcox
BW
$1.46B
$473K ﹤0.01%
129,809
+2,298
+2% +$8.97K
FNHC
2835
DELISTED
FedNat Holding Company Common Stock
FNHC
$472K ﹤0.01%
28,361
ODC icon
2836
Oil-Dri
ODC
$1.25B
$471K ﹤0.01%
25,968
+1,206
+5% +$21.2K
SIC
2837
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$471K ﹤0.01%
52,308
SBBX
2838
DELISTED
SB One Bancorp Common Stock
SBBX
$471K ﹤0.01%
18,869
MPB icon
2839
Mid Penn Bancorp
MPB
$948M
$470K ﹤0.01%
16,303
LEN.B icon
2840
Lennar Class B
LEN.B
$20.5B
$469K ﹤0.01%
11,027
-24,251
-69% -$1.08M
CFFI icon
2841
C&F Financial
CFFI
$282M
$467K ﹤0.01%
8,428
+84
+1% +$4.48K
BREW
2842
DELISTED
Craft Brew Alliance, Inc.
BREW
$467K ﹤0.01%
28,267
+1,546
+6% +$19.3K
LJPC
2843
DELISTED
La Jolla Pharmaceutical Company
LJPC
$467K ﹤0.01%
118,788
-10,577
-8% -$62.5K
FRBA icon
2844
First Bank
FRBA
$456M
$466K ﹤0.01%
42,154
FCCY
2845
DELISTED
1st Constitution Bancorp
FCCY
$465K ﹤0.01%
20,970
+2,793
+15% +$55.8K
CBMG
2846
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$464K ﹤0.01%
28,526
RICK icon
2847
RCI Hospitality Holdings
RICK
$213M
$463K ﹤0.01%
22,572
+1,348
+6% +$26K
RELX icon
2848
RELX
RELX
$62.2B
$460K ﹤0.01%
18,199
RNET
2849
DELISTED
RigNet, Inc.
RNET
$460K ﹤0.01%
69,547
-5,704
-8% -$34.2K
VRCA icon
2850
Verrica Pharmaceuticals
VRCA
$90.9M
$459K ﹤0.01%
2,884
-507
-15% -$74.8K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.